Market Access News | pharmaphorum

News

FDA finally approves Mylan's Advair generic

The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of delays.

News

Brexit could hinder CAR-T reimbursement in Europe

Brexit and the rise of nationalism in Europe could hinder patients' access to pricey CAR-T therapies across Europe, a conference heard.

News

NICE aims to improve communications with UK life sciences

NICE has announced a collaboration with an organisation representing UK life sciences, to improve communications between the cost-effectiveness body and industry.

News

Cystic fibrosis patients lobby Vertex to drop drug prices

Healthcare professionals and patient groups have written to Vertex’s CEO Jeffrey Leiden in a bid to resolve a funding row over cystic fibrosis drugs, as UK MPs prepare to hold a public hear

News

A sad young woman is sitting in her kitchen with a headache

CVS covers migraine drugs from Teva and Lilly, excludes Amge...

US pharmacy benefits manager CVS Health Corp has added new migraine drugs from Teva and Eli Lilly to its list of covered drugs but excluded a rival from Amgen, according to a press report.<

News